Civic AI
Procurement intelligence
Federal contract award
THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE RESIDUAL FUNDING AND CLOSEOUT THE CONTRACT IN ITS ENTITY.
VAXART BIOSCIENCES INC · Department of Health and Human Services
- Value
- $9,271,191
- Start
- Jan 12, 2024
- End
- Oct 31, 2024
- Action date
- Feb 2, 2026
- PIID
- 75A50124C00002
- Status
- completed
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- SOUTH SAN FRANCISCO, CA
- Award type
- DEFINITIVE CONTRACT
Description
THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE RESIDUAL FUNDING AND CLOSEOUT THE CONTRACT IN ITS ENTITY.
Need modifications, related awards, and vendor peers? Open the full award workspace.